NOA device
portable device able of monitoring asthma
disruptive portable device
pharmacies
people
offer
high accuracy
business model
European market
chronic disease
European population
post-treatment monitoring
thorough business plan
high scientific rigor
pneumatics
precise way
FeNO
Fraction of Exhaled Nitric Oxide
technological development
electronics
speed
convenience
departments of allergology
opportunity
test
regard
extent of inflammation
human breath
important advantages
Innovation Project
innovative patent
marker
hospitals
sensors
children
studies
quality of life
price
negative impact
adults
years old
upper airways
ability
clientâ€™s segments
mathematical algorithms
immediate results
seconds
SME Instrument
existence
general objective
risks
pneumology
total cost
Phase
service
basis
early stage
solution
doctors
cure
validity